What should I know first?
CBT-I is a structured treatment for persistent insomnia. It addresses sleep-related habits and worries that can keep sleep difficulties going.
What the Therapy Is
It combines several elements, such as sleep education, cognitive work, stimulus control and an individualized time-in-bed plan. It is more than general sleep-hygiene advice.
How It Works
The aim is to strengthen helpful sleep patterns and reduce worry about sleep. A clinician can tailor the behavioural components rather than applying a universal sleep schedule.
Stimulus control helps restore the connection between bed and sleep. An individualized time-in-bed plan addresses prolonged wakefulness in bed; cognitive work addresses beliefs and worry about sleep, while relaxation can reduce arousal. Sleep hygiene may support treatment, but providing a list of general habits alone is not the same intervention.
Conditions It May Help
NHLBI describes CBT-I as the usual first treatment for long-term insomnia. Co-occurring problems still need assessment.
Typical Session
Treatment may review sleep patterns, discuss sleep-related beliefs and adjust an agreed plan. Delivery can be in person, by phone or online.
A clinician may use sleep records to understand patterns and review changes over a course of treatment. NHLBI describes CBT-I as commonly lasting 6–8 weeks. The plan is adjusted to the person rather than prescribing one bedtime or sleep duration for everyone.
Strength of Evidence
NHLBI supports CBT-I for long-term insomnia. NICE also describes it as the standard initial treatment after sleep-hygiene advice, in its insomnia appraisal context.
The 2025 VA/DoD guideline strongly recommends CBT-I for chronic insomnia. It suggests against sleep-hygiene education as the only treatment and suggests CBT-I before medication, with those latter recommendations rated weak. These distinctions describe recommendation strength, not a guarantee of benefit.
Benefits and Limitations
A structured course can help people learn lasting strategies. Access and format vary; a general self-care app is not equivalent to individualized professional treatment.
Risks and Considerations
The VA advises professional consultation before using its insomnia self-care app for bipolar disorder, epilepsy, marked daytime sleepiness and other relevant conditions. These precautions are not a blanket ban on adapted clinician-delivered CBT-I.
The 2025 VA/DoD guidance calls for adaptation with bipolar disorder or nighttime fall risk. Marked daytime sleepiness may require adaptation or delay; uncontrolled seizures or acute mental-health symptoms may require delaying treatment. These are clinician-assessed precautions, not automatic exclusions. Do not devise a sleep-restriction schedule from this overview; discuss alertness, safety and other sleep conditions with the clinician.
Comparisons
Medication decisions need a prescriber’s input. This educational article does not advise stopping sleeping medication or independently restricting time in bed.
Finding a Professional
Ask about specific CBT-I training and assessment of other sleep disorders.
Before starting, agree the goals, expected format, confidentiality arrangements and how progress will be checked. Ask what happens if symptoms worsen or the approach does not help. In the US, check professional credentials and coverage; in the UK, confirm the relevant local service and its referral requirements. NHS England self-referral information should not be assumed to describe all four UK nations.
History
Morin and colleagues published a randomized trial of behavioural and medication approaches for late-life insomnia in 1999. Its population should not be confused with every age group.
Children and young people
This article’s main treatment account concerns adults. Children need sleep advice adapted to their age and development, with a predictable routine and review of the reasons for poor sleep. A sleep diary can help. An adult sleep-restriction schedule should not be started for a child without an appropriately trained clinician.
Sources and References
Historical studies describe research milestones, not the sole basis for current guidance.
- NHLBI: Insomnia — Treatment
Scope: US.
- VA/DoD: Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea — Provider Summary
Scope: US VA/DoD.
- NICE TA922: Daridorexant for treating long-term insomnia
Scope: NICE technology appraisal; jurisdiction and current funding rules need separate review.
- VA Mobile: Insomnia Coach
Scope: US.
- NIMH: Psychotherapies
Scope: US.
- Morin CM et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial
Scope: Primary research; PubMed record.
- Sleep and young children
Scope: United Kingdom; NICE recommendations require attention to national implementation and local pathways.
- Creating and maintaining a sleep diary
Scope: United Kingdom; NICE recommendations require attention to national implementation and local pathways.
Article Information
- Content updated
- 2026-10-30
- Sources checked
- 2026-10-30
- Publication status
- Published

